US Blocks UN Pandemic Declaration
The United States has prevented the adoption of a landmark political declaration on pandemic prevention, preparedness and response that was scheduled for approval by the United Nations General Assembly on 25 September. In a statement delivered to the assembly, the US delegate indicated it was “not in a position” to endorse the text, thereby blocking consensus—the customary UN method for adopting negotiated documents unless an objection is raised. The move has been described by leading global‑health law expert Professor Lawrence Gostin of Georgetown University as a severe setback for international cooperation.
The declaration, which had been negotiated over months, aimed to unite member states around a common commitment to tackle emerging health threats. It included provisions on technology transfer, equitable access to vaccines and medicines, and the need for solidarity in responding to future pandemics. However, the US delegation’s objection, coupled with a similar rejection from Italy, halted the consensus process. While the European Union expressed full commitment to the overarching goals, its delegate highlighted “red lines” concerning references to intellectual property, particularly whether technology sharing should be voluntary or mandatory—a key sticking point in the ongoing World Health Organization (WHO) treaty talks.
The US decision also reflects deeper policy disagreements. Dr Erica Schwartz, director of the Centres for Disease Control and Prevention, cited unresolved “divisive ideologies that lack definitional consensus” and concerns over language linking the declaration to WHO‑led negotiations on fair sharing of vaccines and drugs. According to sources, the Trump administration was particularly uneasy about passages emphasising equity and universal access to sexual and reproductive health services. Earlier this year, President Trump signed executive orders expanding the “global gag” rule, extending prohibitions on US‑funded organisations from supporting abortion‑related work to include diversity, equity and inclusion initiatives and what the administration termed “gender ideology”.
The United States’ withdrawal from the WHO shortly after Trump’s inauguration further underscores a pattern of disengagement from multilateral health initiatives. Although UN political declarations are not legally binding, they serve as a public signal of intent and a roadmap for coordinated action. “Since this is a political declaration, its value is only as strong as the political will to adopt and implement its provisions,” Gostin observed. “The US decision to dissent severely weakens the document.”
International Reactions and Concerns
Former New Zealand Prime Minister Helen Clark, who co‑chairs the Independent Panel for Pandemic Preparedness and Response, expressed disappointment that the high‑level meeting was not asked to endorse the declaration that member states had negotiated. “Agreeing to collaborate to prevent, prepare for and respond to pandemics should not be controversial,” she said. Similarly, Eloise Todd, founder and executive director of Resilience Action Network International, called the failure to advance the declaration “unacceptable” and a reminder of the challenges in building consensus for the global good in today’s geopolitical climate.
The EU’s delegate, while affirming commitment to the declaration’s goals, warned that certain references to intellectual property could undermine future negotiations. The EU’s stance reflects the broader tension between protecting proprietary medical innovations and ensuring rapid, equitable access during health emergencies. This issue remains a central obstacle in the WHO’s effort to finalise a binding pandemic agreement that would govern pathogen access, data sharing, and benefit‑sharing arrangements.
The declaration’s text also touches on the ongoing WHO‑led discussions about how to allocate vaccines and therapeutics fairly when a new pathogen emerges. Dr Schwartz’s remarks about “divisive ideologies” point to the difficulty of drafting language that can command consensus across a diverse membership with varying cultural, legal, and political perspectives. The inclusion of terms such as “equity” and “universal access” has become flashpoints, especially for governments that view such language as encroaching on sovereign policy decisions.
The Broader Context of Global Health Cooperation
The current impasse occurs against a backdrop of shifting US foreign‑policy priorities and a re‑evaluation of multilateral engagement. For decades, American financing and scientific leadership have underpinned global outbreak detection and response mechanisms. The retreat from consensus‑based processes signals a potential erosion of that leadership, raising questions about who will fill the void in funding, research, and coordination.
The United Nations system has long relied on political declarations as a means to galvanise action without imposing legal obligations. These documents are intended to create a shared vision, encourage best‑practice adoption, and lay the groundwork for more binding agreements down the line. When a major power withdraws support, the ripple effect can be profound, influencing not only the immediate negotiation but also future treaty talks, such as the WHO’s pandemic accord, which remains stalled over issues of pathogen access and benefit sharing.
The Trump administration’s expansion of the global gag rule further complicates the landscape. By extending the ban to encompass diversity, equity and inclusion programmes, the United States is effectively limiting the scope of health‑related assistance that can be provided by its partners. This has ramifications for reproductive health services, gender‑based violence prevention, and broader public‑health initiatives that rely on comprehensive, rights‑based approaches.
Moreover, the US withdrawal from the WHO—formally enacted in July 2020—has left a leadership vacuum within the organisation. While other nations have attempted to step up, the absence of American resources and expertise hampers coordinated responses, particularly in areas such as surveillance, laboratory capacity building, and rapid deployment of medical supplies. The current dispute over the pandemic declaration may accelerate a trend toward regional or ad‑hoc coalitions, potentially fragmenting global health governance.
Impact on Future Pandemic Preparedness
The failure to adopt the declaration at the September meeting means that the political momentum generated by years of negotiation will be lost, at least for the time being. The text is still expected to be reconsidered at a later General Assembly session, where a majority vote could replace the consensus requirement. However, rebuilding the trust and political will necessary for such a vote will be challenging.
If the declaration is ultimately adopted, its provisions could still shape national policies and international norms. Elements such as technology‑transfer mechanisms, transparent data sharing, and equitable access to vaccines are already being incorporated into various bilateral and multilateral agreements. The declaration’s symbolic weight could reinforce these commitments, but without US backing, the global community may struggle to mobilise the resources needed to implement them effectively.
The episode also highlights the fragility of consensus‑based diplomacy in an era of heightened geopolitical competition. As nations grapple with emerging infectious diseases, climate‑driven health threats, and antimicrobial resistance, the ability to mount a unified response becomes ever more critical. The United States’ decision to block the declaration not only hampers immediate pandemic‑prevention efforts but also risks setting a precedent for future negotiations, where major powers may wield veto power through procedural objections rather than substantive debate.
Why it Matters
The United States’ refusal to endorse the UN pandemic preparedness declaration is more than a diplomatic hiccup; it strikes at the heart of global health security. For decades, American leadership in funding, scientific innovation, and cooperative frameworks has been a cornerstone of worldwide outbreak detection and response. By withdrawing that support, the US not only undermines the immediate goal of a unified pandemic plan but also signals a broader retreat from the multilateralism that has proven essential in safeguarding public health. This disengagement threatens to leave gaps in surveillance, weaken equitable access to life‑saving interventions, and erode the trust needed for future cooperation. In an age where a single pathogen can spread across continents within hours, the erosion of collective commitment could prove catastrophic, making the restoration of robust, inclusive global health governance not just a policy priority but a vital imperative for humanity’s survival.